Thus, in addition histopathological findings, such as fibrosis and steatosis, cytokines and metabolic factors, such as insulin resistance, are involved in decreased hepatic TBF in NASH. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.